Expand APLS Menu

APLS Stock Summary and Trading Ideas (Apellis Pharmaceuticals | NASDAQ:APLS)

Charts for Today's Stock Price and Implied Volatility in Apellis Pharmaceuticals


Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for APLS by Theoretical Edge and Win Rates



Viking, CRISPR, Intellia among potential M&A targets: Wells Fargo

Seeking Alpha News (Sat, 25-May 10:24 AM ET)

Trading Statistics

Key Ratios

Apellis Pharmaceuticals (APLS) Frequently Asked Questions

What does Apellis Pharmaceuticals do?

Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.

What symbol and exchange does Apellis Pharmaceuticals stock trade?

Apellis Pharmaceuticals trades on the NASDAQ stock market under the symbol APLS.

What is Apellis Pharmaceuticals stock price doing today?

As of May 24, 2024, APLS stock price climbed to $40.61 with 1,266,202 million shares trading.

What is Apellis Pharmaceuticals's Beta?

APLS has a beta of 1.13, meaning it tends to be more sensitive to market movements. APLS has a correlation of 0.01 to the broad based SPY ETF.

How much is Apellis Pharmaceuticals worth?

APLS has a market cap of $4.93 billion. This is considered a Mid Cap stock.

How much money does Apellis Pharmaceuticals make?

Last quarter Apellis Pharmaceuticals reported $172 million in Revenue and -$.54 earnings per share. This beat revenue expectation by $9 million and missed earnings estimates by -$.02.

What is the highest and lowest price Apellis Pharmaceuticals traded in the last 3 year period?

In the last 3 years, APLS stock traded as high as $94.75 and as low as $19.83.

What are the top ETFs holding Apellis Pharmaceuticals?

The top ETF exchange traded funds that APLS belongs to (by Net Assets): VTI, VB, VXF, VBK, XBI.

Is Apellis Pharmaceuticals (APLS) a good investment?

APLS has underperformed the market in the last year with a price return of -53.1% while the SPY ETF gained +30.4%. APLS has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -40.7% and -3.3%, respectively, while the SPY returned +4.6% and +1.7%, respectively.

What is the support and resistance for Apellis Pharmaceuticals (APLS) stock price?

APLS support price is $37.85 and resistance is $41.51 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that APLS stock will trade within this expected range on the day.